Daratumumab to Treat Active Lupus Nephritis | stella

Learn Data For Researchers Find trials matched to me

Learn Data For Researchers Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Daratumumab to Treat Active Lupus Nephritis | stella

Back to Lupus Nephritis trials

Active, not recruiting

Plain-English translation of NCT04868838 on ClinicalTrials.gov ↗ · Source last updated July 2026 · How we translate trials

Read our Lupus Nephritis research guide →

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(1 site)

United States

Mayo Clinic in Rochester, Rochester, Minnesota

Key details

Phase

Testing effectiveness

Sponsor

Mayo Clinic

Enrollment target

~12 participants

Started

April 2021

Primary completion

September 2026

Age range

18 Years and older

Last updated on clinicaltrials.gov in July 2026.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov